First generic version of AIDS drug approved

updated 2:20 p.m. ET Sept. 20, 2005

WASHINGTON - The FDA has approved the first generic versions of the AIDS medication AZT, a move that could reduce the expense for people in the United States being treated for the disease.

AZT, an anti-retroviral drug that is also known as Zidovudine, helps prevent the AIDS virus from reproducing in the body. It is often used in combination with other medications to treat an HIV infection.

Generic versions of the drug have previously been unavailable in the United States because patent or market exclusivity restrictions prevented them from being marketed.

Now that those patents have expired, versions of drug manufactured by Roxane Laboratories of Columbus, Ohio; Ranbaxy Laboratories of Guragon, India, and Aurobindo Pharma of Hyderabad, India, can go on the market.

Test yourself How much do you know about AIDS?

The original, sold under the name Retrovir, is manufactured by GlaxoSmithKline. The Food and Drug Administration first approved Retrovir in 1987. A 300-milligram tablet can cost $7.

“These approvals will now allow those infected with HIV more access to these life-saving drugs within our country,” said Mike Leavitt, secretary of the Department of Health and Human Services, in a statement.

MORE FROM AIDS

AIDS Section Front

From Haiti, a surprise: good news about AIDS HIV infection rates are highest in the South Calif.: Not so many HIV cases in porn industry? Injected with HIV by dad as baby, teen inspires Engineered antibodies may fight AIDS virus Africa must manufacture own AIDS drugs: U.N. Fauci: Why there is no AIDS vaccine Tobacco plant virus may yield HIV drug Pope: Condoms not the answer in AIDS fight D.C. struggles to contain HIV epidemic AIDS Section Front   Add AIDS headlines to your news reader: